Physiologic action of glucagon on liver glucose metabolism

Diabetes, Obesity and Metabolism

Volumn 13, Issue SUPPL. 1, 2011, Pages 118-125

  Ramnanan, C J ^a   Edgerton, D S ^a   Kraft, G ^a   Cherrington, A D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Exercise; Fasting; Glucagon; Gluconeogenesis; Glucose uptake; Glycogenolysis; Hepatic glucose production; Hyperglycemia; Hypoglycemia

Indexed keywords

ADENYLATE KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCAGON; GLUCOSE; INSULIN;

BURN; DIET RESTRICTION; ENZYME ACTIVATION; EXERCISE; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOGENOLYSIS; HUMAN; HYPERGLUCAGONEMIA; HYPOGLYCEMIA; INJURY; INSULIN RELEASE; LIVER; NONHUMAN; REVIEW; SEPSIS; TACHYPHYLAXIS; TOTAL PARENTERAL NUTRITION;

EID: 79961187989     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2011.01454.x     Document Type: Review

References (38)

1. Cherrington AD. Control of glucose uptake and release by the liver in vivo. Banting Lecture 1997. Diabetes 1999; 48: 1198-1214.
2. Cherrington AD, Chiasson JL, Liljenquist JE et al. The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog. J Clin Invest 1976; 58: 1407-1418.
3. Berglund ED, Lee-Young RS, Lustig DG et al. Hepatic energy state is regulated by glucagon receptor signalling in mice. J Clin Invest 2009; 119: 2412-2422.
4. Wada M, Connolly CC, Tarumi C, Neal DW, Cherrington AD. Hepatic denervation does not change the response of the liver to glucagon in the conscious dog. Am J Physiol 1995; 268: E194-E203.
5. Chu CA, Sindelar D, Neal DW et al. Comparison of the direct and indirect effects of epinephrine on hepatic glucose production. J Clin Invest 1997; 99: 1044-1056.
6. Liljenquist JE, Mueller GL, Cherrington AD et al. Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man. J Clin Invest 1977; 59: 369-374.
7. Burcelin R, Li J, Charron MJ. Cloning and sequence analysis of the murine glucagon receptor-encoding gene. Gene 1995; 164: 305-310.
8. Shulman GI, Williams PE, Liljenquist JE et al. Effect of hyperglycemia independent of changes in insulin or glucagon on lipolysis in the conscious dog. Metabolism 1980; 29: 317-320.
9. Kimball SR, Siegfried BA, Jefferson LS. Glucagon represses signalling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase. J Biol Chem 2004; 279: 54103-54109.
10. Mortimore GE, Neely AN, Cox JR, Guinivan RA. Proteolysis in homogenates of perfused rat liver: responses to insulin, glucagon and amino acids. Biochem Biophys Res Commun 1973; 54: 89-95.
11. Dobbins R, Davis SN, Neal DW, Cobelli C, Cherrington AD. Pulsatility does not alter the metabolic response to a physiologic increment in glucagon in the conscious dog. Am J Physiol 1994; 266: E467-E478.
12. Steiner KE, Williams PE, Lacy WW, Cherrington AD. Effects of insulin on glucagon-stimulated glucose production in the conscious dog. Metabolism 1990; 39: 1325-1333.
13. Cherrington AD, Liljenquist JE, Shulman GI, Williams PE, Lacy WW. Importance of hypoglycemia-induced glucose production during isolated glucagon deficiency. Am J Physiol 1979; 236: E263-E271.
14. Jennings AS, Cherrington AD, Liljenquist JE et al. The roles of insulin and glucagon in the regulation of gluconeogenesis in the postabsorptive dog. Diabetes 1977; 26: 847-856.
15. Myers SR, Diamond MP, Adkins-Marshall BA, Williams PE, Stinsen R, Cherrington AD. Effects of small changes in glucagon on glucose production during a euglycemic, hyperinsulinemic clamp. Metabolism 1991; 40: 66-71.
16. Holste LC, Connolly CC, Moore MC, Neal DW, Cherrington AD. Physiological changes in circulating glucagon alter hepatic glucose disposition during portal glucose delivery. Am J Physiol 1997; 273: E488-E496.
17. Muller WA, Falloona GR, Aguilar-Parada E, Unger RH. Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion. N Engl J Med 1970; 283: 109-115.
18. Shah P, Vella A, Basu A, Basu R, Schwenk WF, Rizza RA. Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab 2000; 85: 4053-4059.
19. Frizzell RT, Hendrick GK, Biggers DW et al. Role of gluconeogenesis in sustaining glucose production during hypoglycemia caused by continuous insulin infusion in the conscious dogs. Diabetes 1988; 37: 749-759.
20. Biggers DW, Myers SR, Neal D et al. Role of brain in counterregulation of insulin-induced hypoglycemia in dogs. Diabetes 1989; 38: 7-16.
21. Gerich JE, Schneider V, Dippe SE et al. Characterization of the glucagon response to hypoglycemia in man. J Clin Endocrinol Metab 1984; 38: 77-82.
22. Cryer PE, Gerich JE. Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus. N Engl J Med 1985; 313: 232-241.
23. Dobbins RL, Connolly CC, Neal DW et al. Role of glucagon in countering the hypoglycemia induced by insulin infusion in dogs. Am J Physiol 1991; 261: E773-E781.
24. Rivera N, Ramnanan CJ, An Z et al. Insulin-induced hypoglycemia increases hepatic sensitivity to glucagon in a canine model. J Clin Invest 2010; 120: 4425-4435.
25. Wasserman DH, Spalding JA, Lacy DB et al. Glucagon is a primary controller of hepatic glycogenolysis and gluconeogenesis during muscular work. Am J Physiol 1989; 257: E108-E117.
26. Cherrington AD, Lacy WW, Chiasson JL. Effect of glucagon on glucose production during insulin deficiency in the dog. J Clin Invest 1978; 62: 664-677.
27. Flattem N, Igawa K, Shiota M, Emshwiller MG, Neal DW, Cherrington AD. Alpha and beta cell responses to small changes in plasma glucose in the conscious dog. Diabetes 2001; 50: 367-375.
28. Cooperberg BA, Cryer PE. Insulin reciprocally regulates glucagon secretion in humans. Diabetes 2010; 59: 2936-2940.
29. Edgerton DS, Cherrington AD. Glucagon as a critical factor in the pathology of diabetes. Diabetes 2011; 60: 377-380.
30. Stevenson RW, Williams PE, Cherrington AD. Role of glucagon suppression on gluconeogenesis during insulin treatment of the conscious diabetic dog. Diabetologia 1987; 30: 782-790.
31. Mcguinness OP. Defective glucose homeostasis during infection. Annu Rev Nutr 2005; 25: 9-35.
32. Chen SS, Donmoyer CM, Pearson DA et al. Impact of infection on glucose-dependent liver glucose uptake during TPN: interaction with insulin. Am J Physiol Endocrinol Metab 2004; 286: E286-E295.
33. van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367.
34. Mcguinness OP, Lacy DB, Anderson J. Effect of acute glucagon removal on metabolic response to infection in conscious dog. Am J Physiol 1995; 268: E92-E99.
35. Chen SS, Torres-Sanchez CJ, Hosein N et al. Time course of the hepatic adaptation to TPN: interaction with glycogen depletion. Am J Physiol Endocrinol Metab 2005; 288: E163-E170.
36. Mcguinness OP, Donmoyer C, Ejiofor J, McElligott S, Lacy DB. Hepatic and muscle glucose metabolism during total parenteral nutrition: impact of infection. Am J Physiol 1998; 275: E763-E769.
37. Chen SS, Zhang Y, Santomango TS et al. Glucagon chronically impairs hepatic and muscle glucose disposal. Am J Physiol Endocrinol Metab 2007; 292: E928-E935.
38. Chen SS, Santomango TS, Williams PE, Lacy DB, Mcguinness OP. Glucagon-mediated impairments in hepatic and peripheral tissue nutrient disposal are not aggravated by increased lipid availability. Am J Physiol Endocrinol Metab 2009; 296: E1172-E1178.